The DOI matches its Crossref record.
Serum Calcitonin Precursors in Sepsis and Systemic Inflammation1
Abstract
High serum levels of the calcitonin (CT) prohormone, procalcitonin (pro-CT), and its component peptides occur in systemic inflammation and sepsis. Using two different assays, we undertook a prospective study to determine the utility of serum precalcitonin peptides (pre-CT) as markers in this condition. Twenty-nine patients meeting criteria for the systemic inflammatory response syndrome were studied daily in two intensive care units. Sera were collected, and APACHE II scores were determined until recovery or death. All patients had markedly elevated serum pre-CT. Prognostically, peak values were the most important. The highest values portended mortality, and a lower level could be ascertained below which all patients survived. Peak pre-CT levels were significantly higher in patients with infection documented by blood cultures than in those patients with no documented infection from any source (P < 0.05). Mature CT remained normal or only moderately elevated. Compared with the serum pre-CT levels, receiver operating characteristic curve analysis revealed that the APACHE II scores, although more cumbersome, were better overall predictors of mortality. Thus, pre-CT is an important serum marker for systemic inflammatory response syndrome and is predictive of outcome. It also provides data concerning the presence of severe infection and may prove to be clinically useful for proactive patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Self-citationBecker, K. L., Snider, R., & Nylen, E. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318165babb · Cited by 598
Self-citationBecker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Self-citationUbiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis1
Müller, B., White, J. C., Nylén, E. S., Snider, R. H., Becker, K. L., & Habener, J. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7089 · Cited by 440
Self-citationProphylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
Skinner, M. A., Moley, J. A., Dilley, W. G., Owzar, K., DeBenedetti, M. K., & Wells, S. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043999 · Cited by 381
Procalcitonin in bacterial infections - hype, hope, more or less?
Christ-Carin, M. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11169 · Cited by 367
Linscheid, P., Seboek, D., Nylen, E. S., Langer, I., Schlatter, M., Becker, K. L., Keller, U., & Müller, B. (2003) · Endocrinology · doi:10.1210/en.2003-0854 · Cited by 359
Self-citationProcalcitonin as an early marker of infection in neonates and children
van Rossum, A., Wulkan, R., & Oudesluys-Murphy, A. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01146-6 · Cited by 310
Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target
Becker, K. L., Snider, R., & Nylen, E. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00433.x · Cited by 309
Self-citationHypocalcemia: A pervasive metabolic abnormality in the critically ill
Zivin, J. R., Gooley, T., Zager, R. A., & Ryan, M. J. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80116-5 · Cited by 263
Immune Activation in Retinal Aging: A Gene Expression Study
Chen, M., Muckersie, E., Forrester, J. V., & Xu, H. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-5103 · Cited by 130
Biochemical Testing in Thyroid Disorders
Esfandiari, N. H., & Papaleontiou, M. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.04.002 · Cited by 50
Calcitonin as a biomarker of C cell disease: recent achievements and current challenges
Costante, G., & Meringolo, D. (2020) · Endocrine · doi:10.1007/s12020-019-02183-6 · Cited by 41
Metadata
- Authors
- Whang, K. T., Steinwald, P. M., White, J. C., Nylen, E. S., Snider, R. H., Simon, G. L., Goldberg, R. L., & Becker, K. L.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-09
- Volume
- 83
- Issue
- 9
- Pages
- 3296-3301
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2158730983
- Cited by
- 161
- References
- 0
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.